These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21906492)

  • 1. Cutaneous melanoma in patients in treatment with biological therapy: review of the literature and case report.
    Manganoni AM; Zane C; Pavoni L; Farisoglio C; Sereni E; Calzavara-Pinton P
    Dermatol Online J; 2011 Aug; 17(8):12. PubMed ID: 21906492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
    Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D
    Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple malignant melanomas in a patient with RA treated with methotrexate.
    Potter T; Hardwick N; Mulherin D
    J Rheumatol; 1998 Nov; 25(11):2282-3. PubMed ID: 9818680
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of two primary malignant melanomas after treatment with adalimumab: a case report and review of the possible link between biological therapy with TNF-alpha antagonists and melanocytic proliferation.
    Katoulis AC; Kanelleas A; Zambacos G; Panayiotides I; Stavrianeas NG
    Dermatology; 2010 Aug; 221(1):9-12. PubMed ID: 20484878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insight into rheumatoid arthritis management. The disease and the drugs used to treat it have been linked to cardiovascular disease, melanoma, and fracture.
    Duke Med Health News; 2012 Feb; 18(2):1-2. PubMed ID: 22397007
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous pseudolymphoma during treatment of rheumatoid polyarthritis with low-dose methotrexate].
    Delaporte E; Catteau B; Cardon T; Flipo RM; Lecomte-Houcke M; Piette F; Delcambre B; Bergoend H
    Ann Dermatol Venereol; 1995; 122(8):521-5. PubMed ID: 8572492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous melanoma: a complication of infliximab treatment?
    Khan I; Rahman L; McKenna DB
    Clin Exp Dermatol; 2009 Jun; 34(4):524-6. PubMed ID: 19196307
    [No Abstract]   [Full Text] [Related]  

  • 9. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
    Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT
    Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis.
    Fam AG; Perez-Ordonez B; Imrie K
    J Rheumatol; 2000 Jun; 27(6):1546-9. PubMed ID: 10852288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate.
    Nakashima C; Tanioka M; Takahashi K; Miyachi Y
    Clin Exp Dermatol; 2008 Jul; 33(4):437-9. PubMed ID: 18485021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of methotrexate, rheumatoid arthritis, and melanoma in 2 patients.
    Jeannou J; Goupille P; Valat JP
    J Rheumatol; 1997 Jul; 24(7):1444-5. PubMed ID: 9228153
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.
    Greenwald MW; Shergy WJ; Kaine JL; Sweetser MT; Gilder K; Linnik MD
    Arthritis Rheum; 2011 Mar; 63(3):622-32. PubMed ID: 21360491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pembrolizumab-associated inflammatory myopathy.
    Gandiga PC; Wang AR; Gonzalez-Rivera T; Sreih AG
    Rheumatology (Oxford); 2018 Feb; 57(2):397-398. PubMed ID: 29088490
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal varicella-zoster virus vasculopathy associated with adalimumab therapy.
    Baek W; Lee SG; Kim YS; Kim JH; Jun JB; Kim HY
    Arch Neurol; 2012 Sep; 69(9):1193-6. PubMed ID: 22732856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple primary malignant melanomas in psoriasis vulgaris under long-term methotrexate therapy].
    Wemmer U
    Z Hautkr; 1984 May; 59(10):665-8. PubMed ID: 6429960
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin reaction to adalimumab.
    Beuthien W; Mellinghoff HU; von Kempis J
    Arthritis Rheum; 2004 May; 50(5):1690-2. PubMed ID: 15146441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-onset psoriasis associated with adalimumab: a report of two cases.
    Glenn CJ; Kobraei KB; Russo JJ
    Dermatol Online J; 2011 Sep; 17(9):15. PubMed ID: 21971280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composite cutaneous lymphoma in a patient with rheumatoid arthritis treated with methotrexate.
    Huwait H; Wang B; Shustik C; Michel RP
    Am J Dermatopathol; 2010 Feb; 32(1):65-70. PubMed ID: 20098085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab.
    Wilson ML; Sewell LD; Mowad CM
    J Drugs Dermatol; 2008 Jan; 7(1):53-4. PubMed ID: 18246698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.